(Laguna Niguel, CA) July 20, 2004- Atrium Biotechnologies Inc. has chosen to tap into LTP’s expertise to build strong relationships between Atrium, its recently acquired company, Pure Encapsulations, and healthcare practitioners in the nutraceutical industry.
LTP will be conducting peer-to-peer advisory sessions for Atrium and its Pure Encapsulations customer base in order to expand their business in the Practitioner Market. LTP has coined the phrase “Natural Product Advisory SessionsTM” (NPASTM) to describe this service. Joining forces with experts who offer this innovative sales/marketing service to “Big Pharma,” LTP has designed and perfected a program that meets the unique needs of nutraceutical companies interested in the practitioner distribution channel.
“Conducting NPASTM sessions for Atrium and its Pure customers will enable Atrium to build long term, loyal, and lucrative relationships within the practitioner channel. With Atrium’s recent acquisition of Pure Encapsulations, NPASTM and other strategic marketing initiatives executed by LTP, will maximize their opportunity for sales growth among their new network of more than 36,000 physicians and other healthcare professionals and their new addition of more than 270 quality nutritional supplement products,” said Noah Miller, President of LTP.
About Longevity Through Prevention Inc. (LTP)
Longevity Through Prevention, Inc. is a business-to-business consulting firm that offers turnkey training, scientific marketing, sales, technology and business solutions to the pharmaceutical and natural products industry. LTP offers peer-to-peer Natural Product Advisory SessionsTMTM
Visit LTP online at http://www.LTPonline.com.
Contact: Noah Miller (866) 587-4622 x708 or [email protected]
About Atrium Biotechnologies Inc.
Atrium, a subsidiary of Æterna Laboratories Inc., develops and markets active ingredients
and specialty fine chemicals in the health and personal care industry for the cosmetics, chemical, pharmaceutical and nutritional industries. Its international business network and portfolio include 800 products sold to over 2,000 institutional customers including Estée Lauder, L'Oréal, Clarins, Chanel, Aventis, SanofiSynthelabo and Nestlé. In 2003, Atrium sales exceeded $120 million. Atrium and its subsidiaries have 150 employees in Canada, the United States and in Europe.
About Pure Encapsulations Inc.
Pure Encapsulations Inc, a privately-held company focused mainly on the development, manufacturing and marketing of nutritional supplements for physicians and other healthcare professionals. With sales exceeding $25 million in 2003, Pure is among the leaders in this growing specialized sector which generates annual sales of over $1 billion in the United States.
About Æterna Laboratories
Æterna Laboratories Inc. along with its wholly-owned subsidiary Zentaris GmbH, is a biopharmaceutical company with an extensive product portfolio, including two marketed products and several other product candidates under development in oncology, endocrinology and infectious diseases. Æterna shares are listed on the Toronto Stock Exchange (AEL) and the NASDAQ National Market (AELA).